stock
None
NYSE:ABBV
144.50
-2.77 (-1.88%)
As of 2023-02-02, 12:33 PM (EST)
52 Week Rng -
Market Cap -
Avg Volume -
1M Volatility -
Short Ratio -
P/E Ratio (TTM) -
P/E Ratio (Fwd) -
P/B Ratio -
Div & Yield -
SELL
340
Filled
ACTION
TICKER
SHARES
STATUS
BUY
10
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
200
Filled
ACTION
TICKER
SHARES
STATUS
BUY
100
Filled
ACTION
TICKER
SHARES
STATUS
BUY
612
Filled
ACTION
TICKER
SHARES
STATUS
SELL
136
Filled
ACTION
TICKER
SHARES
STATUS

Novemberbets Aalto Investments game (Fall 2022) Nov 2022

Given that the 50-day moving average is lower than the 200-day moving average means that the asset is possibly in bear market. Also, that the current price is higher than the 1 month low, which makes it likely that the stock price will fall in the near future. The stock has fallen over a week so there is momentum in that direction.

BUY
599
Filled
ACTION
TICKER
SHARES
STATUS

Alphahunter Aalto Investments game (Fall 2022) Oct 2022

Momentum strategy based on RSI 14 days closing prices. Buy if RSI over 50 and short if under 50.

BUY
85
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
30
Filled
ACTION
TICKER
SHARES
STATUS
BUY
100
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
200
Filled
ACTION
TICKER
SHARES
STATUS
BUY
1,000
Filled
ACTION
TICKER
SHARES
STATUS
BUY
100
Filled
ACTION
TICKER
SHARES
STATUS
BUY
50
Filled
ACTION
TICKER
SHARES
STATUS
BUY
700
Filled
ACTION
TICKER
SHARES
STATUS

IRAM2022Team1 IRAM 2022 Mar 2022

From financials, abbvie not only has revenues but also profits, which is a demonstration of value generation and therefore a good fit for long-only investment. Abbvie's EPS has been growing steadily over the years and its most recent EPS growth rate reaches 21% over the three years. Abbvie's EBIT margins are steadily maintained over the last year as well. From activities, Abbvie very recently buys Belgian drug company Syndesi Therapeutics for about $130 million to give it ownership of the firm in neuroscience field like cognitive decline and depression. Building upon company's expertise in immunology, the firm will now have more development in neuroscience field as well, which represents potentials in growth from such diversification.

[SELL]
30
Filled
ACTION
TICKER
SHARES
STATUS
BUY
300
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
100
Filled
ACTION
TICKER
SHARES
STATUS
BUY
4
×
ACTION
TICKER
SHARES
STATUS
SELL
10
Filled
ACTION
TICKER
SHARES
STATUS

WSmursus Aalto Investment management game (Fall 2021) Dec 2021

Monthly Rebalance / Buying and selling Top 50 Market cap S&P 500 stocks to achieve target weights of max 2% per stock

more
AAPL AMZN TSLA MSFT DIS AAPL AMZN MRO BP SJM
Market data provided by Xignite, BATS BZX Real-Time Price, and SIX Financial Information.